Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares U.S. Healthcare ETF (IYH) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. Both IYH and IHE have the same Total Expense Ratio (TER) of 0.38%. IYH is down -1.84% year-to-date (YTD) with -$496M in YTD flows. IHE performs better with 4.3% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of IYH and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IYH IHE | -2.08%-1.82% | -0.90%+5.93% | -1.84%+4.30% | +6.00%+28.47% | +25.78%+63.32% | +36.39%+61.21% |
| Flows | IYH IHE | -$245M+$9M | -$580M+$154M | -$496M+$129M | -$318M+$248M | -$643M+$359M | -$164M+$393M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IYH IHE | +13.70%+15.86% | +17.71%+20.40% | +13.80%+15.94% | +14.71%+15.80% |
| Max drawdown | IYH IHE | -5.23%-4.49% | -12.43%-14.18% | -17.89%-16.04% | -17.89%-16.12% |
| Max drawdown duration | IYH IHE | 63d10d | 211d150d | 445d210d | 445d669d |
IYH | IHE | |
Last sale 3/12/2026 at 2:13 PM | $63.60 | $87.05 |
| Previous close 03/11/2026 | $63.88 | $88.40 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IYH | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IYH | IHE | |
|---|---|---|
| Last price | $63.60 | $87.05 |
| 1D performance | -0.45% | -1.53% |
| AuM | $3.02 B | $1.02 B |
| E/R | 0.38% | 0.38% |
IYH | IHE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | iShares |
| Benchmark | Russell 1000 Health Care RIC 22.5/45 Capped Gross Index | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 96 | 46 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2000 | May 1, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
